Pequeñas Acciones, Disfruta tu día, online, Takoradi, May 29 to May 30

First of all, I can’t believe there’s any question about this – of course they should! But more importantly who thinks that questions of priority actually get decided by carefully scrutinizing who published what, when and on what date? I mainly looked at Nature, Nature Cell Biology, Journal of Cell Biology, EMBO Journal and J Cell Science. Using citations in 2012 articles to papers published in 2010 and 2011, i.e. the same criteria as for IF2012.

• In terms of making the knowledge of the world available to the people who are the rightful owners, this woman, Alexandra Elbakyan, has single-handedly been more successful than all OA advocates and activists over the last 20 years combined.
• Scientists who engage in post-publication review often do so out of a sense of duty to their community, but this important work does not come with the same prestige as other scientific endeavours.
• The JIF is used in some institutions in the criteria for hiring, promotion and firing.
• In the course of assembling weekly lists of articles in our field, we began noticing more peer-reviewed articles containing what we call substantial or invalidating errors.
• However, complaints are also used to undermine researchers doing legitimate but controversial science3.
• We spent 30 minutes talking about whether pre-prints should count in establishing priority for discoveries.

The VW Group previously said prototypes will be unveiled in 2023 with styling cues inspired by the 1960s iconic off-roader. Rumours have linked Scout with a possible technical tie-up with Ford. Volkswagen’s Commerical Vehicles division already co-operates with the company on the Amarok pick-up truck, which was designed, developed alongside the latest Ford Ranger. https://1investing.in/ However, Volkswagen has so far denied any involvement between Scout and Ford. Together with the new website, Scout has also established a community forum and registry to “chronicle classic Scout vehicles, to connect owners and to share personal photos and stories”. Get live Share Market updates and latest India News and business news on Financial Express.

By April of 1994, the Agreement on Trade-Related Aspects of Intellectual Property Rights, a k a TRIPS, was signed by 123 government ministers. The deal was one of the foundational documents of the World Trade Organization, and immediately became the most significant intellectual property agreement of modern times. When governments don’t take a sufficiently activist role in the field of medicines, public opinion pushes them further. In the 1990s and 2000s, advocates gave voice to passionate outrage over the devastating human cost of patent-priced HIV/AIDS medicines, which limited access to sufferers who could afford expensive treatments. US activists threw the ashes of AIDS victims on the lawn of the White House, while African activists called treatment-resistant government ministers murderers. The protests led to the dismantling of patent price barriers—and then to massive public programs to distribute the medicine at low or no cost.

One of the goals of scientific skepticism is to examine the process of science itself, often through the lens of pseudoscience. I find this remarkably helpful, and something that many mainstream scientists often do not understand. This is all done to prevent researchers from ‘data-dredging’ their results. If researchers switch from these pre-specified outcomes, without explaining that they have done so, then they break the assumptions of their statistical tests. That carries a significant risk of exaggerating findings, or simply getting them wrong, and this in turn helps to explain why so many trial results eventually turn out to be incorrect. These initiatives can generate conflict, because they set out to hold individuals to account.

For many nations, that flexibility meant excluding medicines from patent protection. For example, Germany’s patent law of 1877 labeled medicines as “essential goods,” along with food and chemicals, and prohibited any attempts to patent them. But even from within the OA community Alexandra Elbakyan is receiving some flak for a whole host of – compared to 48 million freed articles – tangential reasons, such as licensing, diluting the OA efforts, or scholarly societies. Of course, she reacted defensively, which is understandable for a host of reasons. However, one shouldn’t necessarily see these comments as criticism.

Minor corrections and clarifications after publication should not be a reason to stigmatize fellow researchers. Scientific publications should be seen as ‘living documents’, with corrigenda an accepted — if unwelcome — part of scientific progress. We suspect that explicit discussion of what data are and are not available as part of the original publication process might have averted some of the ongoing controversy surrounding the PACE clinical trial, a UK study on chronic fatigue syndrome. The issue involves requests for data by transparency advocates, and the refusal by researchers and institutions to release data citing patient confidentiality, limited consent and requestors’ intent.

by 6″ postcard print, “Gnome” Altered Thrift Store Art…

The inefficiency of the enclosed medicine is paired with the creation of real barriers to medicine innovation across the board. By definition, a reward system based on artificial exclusivity will wall off knowledge from being shared. For-profit pharmaceutical corporations are known for discouraging innovations by creating voluminous “packet thickets” and seeking extended protection for their monopolies in a process known as “evergreening” their patents. But there was little in the way of binding international law to back up that position. So the industry pushed directly for the US government to make intellectual-property protection a priority in all trade negotiations.

You may also opt to downgrade to Standard Digital, a robust journalistic offering that fulfils many user’s needs. Change the plan you will roll onto at any time during your trial by visiting the “Settings & Account” section. During your trial you will have complete digital access to FT.com with everything in both of our Standard Digital and Premium Digital packages.

The answer to why Thomson-Reuters don’t do this is probably for ease of computation. The JIF requires only three numbers for each journal, whereas calculating the median would require citation information for each paper under consideration for each journal. There’s also a mismatch in the items that bring in citations to the numerator and those that count as “citeable items” in the denominator. This opacity is one of the major criticisms of the Impact Factor and this presents a problem for them to calculate the median. In one case, we chose to post a comment on the journal website and on PubMed Commons after months of private correspondence, in which the authors shared some supplementary data and said that they were preparing a full response.

Volkswagen-owned Scout Motors provides an early glimpse of its rugged electric vehicle.

The only thing that matters to me is making sure that the people who attended the meeting and who seemed really energized about making pre-prints work start to put this enthusiasm into practice immediately. But the immediate What Is a Good Sharpe Ratio goal of the scientists at the meeting or who support its goals must be to start posting pre-prints. There were four Nobelists at the meeting, many members of national academies, and other A-list scientists.

I had a closer look at citation data for a small number of journals in my field. DC’s citation distribution plot was great but it didn’t capture the distribution that underlies the JIF. My intention was to redo this analysis more fully in June 2014 when the IF2013 was released, but I was busy, had lost interest and the company said that they would be more open with the data (although I’ve not seen any evidence for this). I wrote about partial impact factors instead, which took over my blog.

Recognizing and incentivizing such activities could go a long way to cleaning up the literature. Journals, publishers and scientific societies should standardize, streamline and publicize these processes. Authors and journals should share data and code quickly when questions arise. Researchers can aid this process by accessing statistical expertise for experimental design and analysis.

As with any new development, there are unintended consequences. Many measures that can improve science2 — shared data, post-publication peer review and public engagement on social media — can be turned against scientists. Although online platforms such as PubMed Commons offer a convenient way to comment on published papers, they do not include a mediating role for journal editors, and the comments are not incorporated into the literature. Posted concerns are rarely prominent on journals’ websites and are not cross-referenced in any useful way. As a result, readers may assume that a flawed paper is correct, potentially leading to misinformed decisions in science, patient care and public policy.

Latest technical analysis

The menu pricing comprises of all the costs that a customer could potentially incur, depending on the service required on the respective model. The search was limited to the English language and the last search of the literature was conducted on August 5th, 2015. If no inclusion criteria were evaluated as being met and/or any exclusion criteria were met, the initiative was removed from the mapping.

This is long-standing best practice, because an outcome such as ‘cardiovascular health’ could be measured in many ways. So researchers are expected to list the specific blood tests and symptom-rating scales that they will use, for example, alongside the dates on which measurements will be taken, and any cut-off values they will apply to turn continuous data into categorical variables. Our work was not a systematic search; we simply looked more closely at papers that caught our eye and that we were prepared to assess. We do not know the rate of errors or the motivations behind them (that is, whether they are honest mistakes or a ‘sleight of statistics’). But we showed that a small team of investigators with expertise in statistics and experimental design could find dozens of problematic papers while keeping abreast of the literature.

We are targeting the problem of selective outcome reporting in clinical trials. In these studies, all participants in a cluster are given the same treatment. Otherwise, results often seem, falsely, to be statistically significant8, 9. Increasing the number of individuals within clusters can increase power, but the gains are minute compared with increasing clusters. Designs with only one cluster per treatment are not valid as randomized experiments, regardless of how many individuals are included.

MSF joined several organizations in using negotiations over the massive Trans-Pacific Partnership agreement as a platform for activism on medicine access. “Letters patent,” meaning open letters, were issued in 14th-century England to induce foreign craftsmen to relocate there. Attempts to coordinate global intellectual property rules led to the 1883 Paris Convention and the 1886 Berne Convention, and eventually to the creation of the United Nations’s World Intellectual Property Organization in 1967. But nations who signed on to those agreements retained the ability to determine the length of patents and what products would be covered.

Thomson Reuters Products

Of course, inserting monopoly patent rights into trade agreements runs counter to those agreements’s stated purpose of dismantling barriers to global competition. Yet the pharmaceutical industry, reliably at the top of the list in both lobbying expenditures and political campaign contributions in the United States, quickly found willing partners on Capitol Hill and in the White House. The United States soon adopted intellectual property protection as a litmus test for its trade partners. The first step in that effort was countering the dominant international view that medicine compounds were not private property that could or should be owned by companies and individuals.

Host Events

Some journals and publishers are already moving towards this practice . Calls for a data set that ignore its open availability could suggest harassment. Quite clearly , for Mr. Esposito, access to the scholarly literature is a privilege worth paying for. Moreover, he sees no need to negotiate this position any further. Inasmuch as this opinion instructs his advice to publishers, scholars should not be surprised, for instance, that publishers actively block contentmining and will not negotiate about this blockade of science.

If the company is to see its plans through, it will almost certainly need much more money. Browse 118 bolsa stock videos and clips available to use in your projects, or search for bolsa madrid or bolsa chica to find more stock footage and b-roll video clips. Volkswagen CEO said two days ago they expect a strong second half of 2022. The company stated chip shortages are easing that will help increase electric vehicle production volumes in its biggest markets in Germany and China.